| Date Filed | Type | Description |
| 09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2023 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 18,000 shares
@ $0.5947, valued at
$10.7k
|
|
| 05/02/2023 |
4
| Jackman Stephan (CEO) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 37,000 shares
@ $0.5405, valued at
$20k
|
|
| 03/23/2023 |
4
| McGrath Lynne Fahey (Director) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 10,000 shares
@ $0.435, valued at
$4.4k
|
|
| 03/20/2023 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 4,000 shares
@ $0.5014, valued at
$2k
Bought 5,000 shares
@ $0.4298, valued at
$2.1k
|
|
| 02/28/2023 |
4
| Horne William B. (Director) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Exercised 500,000 options to buy
@ $0.004, valued at
$2k
|
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 5,000 shares
@ $0.8099, valued at
$4k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 6,000 shares
@ $1.1893, valued at
$7.1k
|
|
| 10/14/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 2,000 shares
@ $1.2334, valued at
$2.5k
|
|
| 10/07/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 1,000 shares
@ $1.4293, valued at
$1.4k
|
|
| 09/30/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 3,500 shares
@ $1.1865, valued at
$4.2k
|
|
| 09/26/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Acquired 73,500 shares
@ $0.945, valued at
$69.5k
|
|
| 09/20/2022 |
4
| Jackman Stephan (CEO) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 8,500 shares
@ $1.2252, valued at
$10.4k
|
|
| 09/14/2022 |
4
| Katzoff David J (CFO) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 10,000 shares
@ $1.1092, valued at
$11.1k
|
|
| 08/29/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 9,100 shares
@ $0.9408, valued at
$8.6k
|
|
| 08/26/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 4,900 shares
@ $0.9599, valued at
$4.7k
|
|
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2022 |
4
| AULT MILTON C III (10% Owner) has filed a Form 4 on Alzamend Neuro, Inc.|
Txns:
| Bought 5,700 shares
@ $0.87, valued at
$5k
|
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|